Jia Jie Biomedical Co (ROCO:4109) Total Equity: NT$1,714.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4109 Jia Jie Biomedical Co Ltd ROCO:4109
64 GF Score
Price NT$11.75
GF Value NT$16.95
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Jia Jie Biomedical Co Total Equity?

Jia Jie Biomedical Co ROCO:4109 -2.89% 64 Total Equity is NT$1,714.0 Mil as of Dec. 2025. GuruFocus rates ROCO:4109 with a GF Score™ of 64/100 and a GF Value™ of NT$16.95 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Jia Jie Biomedical Co's total equity for the quarter that ended in Dec. 2025 was NT$1,714.0 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Jia Jie Biomedical Co Total Equity Historical Data

* Premium members only.

The historical data trend for Jia Jie Biomedical Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jia Jie Biomedical Co Total Equity Chart

Jia Jie Biomedical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 934.92 923.96 1,070.22 1,359.20 1,714.00

Jia Jie Biomedical Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,359.20 1,673.54 1,665.32 1,680.25 1,714.00
ROCO:4109
64GF Score
Jia Jie Biomedical Co Ltd ROCO:4109
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jia Jie Biomedical Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Jia Jie Biomedical Co's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=1888.888-174.886
=1,714.0

Jia Jie Biomedical Co's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=1888.888-174.886
=1,714.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of NT$1,714.0 Mil mean?
Jia Jie Biomedical Co (ROCO:4109) has a Total Equity of NT$1,714.0 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Jia Jie Biomedical Co and its competitors.
Is Jia Jie Biomedical Co's Total Equity too high?
Jia Jie Biomedical Co's current Total Equity is NT$1,714.0 Mil. Overall, Jia Jie Biomedical Co has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jia Jie Biomedical Co's Total Equity compare to KHC and GIS?
Jia Jie Biomedical Co's Total Equity of NT$1,714.0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Consumer Packaged Goods company?
A good Total Equity depends on the Consumer Packaged Goods industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Jia Jie Biomedical Co and its competitors. Jia Jie Biomedical Co's current Total Equity is NT$1,714.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jia Jie Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Jia Jie Biomedical Co (ROCO:4109) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$16.95, compared to a current price of NT$11.75 — trading 30.7% below its estimated fair value. The current Total Equity is NT$1,714.0 Mil. Jia Jie Biomedical Co's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Jia Jie Biomedical Co (ROCO:4109), the current Total Equity is NT$1,714.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jia Jie Biomedical Co (ROCO:4109) Overvalued in 2026?

Based on GuruFocus' analysis, Jia Jie Biomedical Co stock appears to be undervalued. The current stock price of NT$11.75 is trading 30.7% below its estimated GF Value™ of NT$16.95. GuruFocus considers Jia Jie Biomedical Co to be Significantly Undervalued.

Key valuation signals for ROCO:4109:

  • Total Equity: NT$1,714.0 Mil
  • GF Value™: NT$16.95 vs. price of NT$11.75 (30.7% below fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the ROCO:4109 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jia Jie Biomedical Co Business Description

Address Jiuru 1st Road, 3rd Floor, No. 61, Sanmin District, Kaohsiung City, TWN, 807
Jia Jie Biomedical Co Ltd is a Taiwan-based company. The Company is engaged in the processing, sale, and trading of softshell turtle food, the Manufacture of Dairy Products, and miscellaneous food manufacturing (e.g., softshell turtle egg powder capsules, enzyme powder, tortoise jelly, softshell turtle oil, and powder capsules). The company is also engaged in the import, export of the aforementioned products, the distribution, bidding, and quotation of aforementioned products for domestic and foreign manufacturers, Wholesale of Nonalcoholic Beverages, candy wholesale, baked food wholesale, supplementary food wholesale, cosmetics wholesale, and sports equipment wholesale.
64GF Score

Get the complete analysis for ROCO:4109

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$11.75
Price
NT$16.95
GF Value